Shots:
The US FDA has approved neffy 1mg (epinephrine nasal spray) to treat type I allergic reactions (incl. anaphylaxis) in children [≥4yrs. & 15-30kg (33-66lbs)]; commercially available in the US by end of May’25
Approval was based on extensive clinical data with PK/PD results comparable to approved epinephrine injections in both pediatric & adult…
